These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6260340)

  • 61. How to Make Anticancer Drugs Cross the Blood-Brain Barrier to Treat Brain Metastases.
    Angeli E; Nguyen TT; Janin A; Bousquet G
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861465
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mind the Gaps: Ontogeny of Human Brain P-gp and Its Impact on Drug Toxicity.
    Nicolas JM; de Lange ECM
    AAPS J; 2019 May; 21(4):67. PubMed ID: 31140038
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical pharmacokinetics and effects of vincristine sulfate in dogs with transmissible venereal tumor (TVT).
    Hantrakul S; Klangkaew N; Kunakornsawat S; Tansatit T; Poapolathep A; Kumagai S; Poapolathep S
    J Vet Med Sci; 2014 Dec; 76(12):1549-53. PubMed ID: 25649934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of chemotherapeutics on organotypic corticostriatal slice cultures identified by a panel of fluorescent and immunohistochemical markers.
    Nørregaard A; Jensen SS; Kolenda J; Aaberg-Jessen C; Christensen KG; Jensen PH; Schrøder HD; Kristensen BW
    Neurotox Res; 2012 Jul; 22(1):43-58. PubMed ID: 22203610
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Influence of blood-brain barrier efflux pumps on the distribution of vincristine in brain and brain tumors.
    Wang F; Zhou F; Kruh GD; Gallo JM
    Neuro Oncol; 2010 Oct; 12(10):1043-9. PubMed ID: 20501632
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Childhood medulloblastoma: current status of biology and treatment.
    Klesse LJ; Bowers DC
    CNS Drugs; 2010 Apr; 24(4):285-301. PubMed ID: 20297854
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacokinetic considerations in the treatment of CNS tumours.
    Motl S; Zhuang Y; Waters CM; Stewart CF
    Clin Pharmacokinet; 2006; 45(9):871-903. PubMed ID: 16928151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long-term effects of vincristine on the peripheral nervous system.
    Postma TJ; Benard BA; Huijgens PC; Ossenkoppele GJ; Heimans JJ
    J Neurooncol; 1993 Jan; 15(1):23-7. PubMed ID: 8384253
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.
    Kiburg B; van de Loosdrecht AA; Schweitzer KM; Ossenkoppele GJ; Müller LJ; Heimans JJ; Huijgens PC
    Br J Cancer; 1994 Mar; 69(3):497-501. PubMed ID: 8123480
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Concentration of vinblastine in human intracerebral tumor and other tissues.
    Stewart DJ; Lu K; Benjamin RS; Leavens ME; Luna M; Yap HY; Loo TL
    J Neurooncol; 1983; 1(2):139-44. PubMed ID: 6678966
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical pharmacokinetics of commonly used anticancer drugs.
    Balis FM; Holcenberg JS; Bleyer WA
    Clin Pharmacokinet; 1983; 8(3):202-32. PubMed ID: 6189661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
    Cordon-Cardo C; O'Brien JP; Casals D; Rittman-Grauer L; Biedler JL; Melamed MR; Bertino JR
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):695-8. PubMed ID: 2563168
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Brain uptake and anticancer activities of vincristine and vinblastine are restricted by their low cerebrovascular permeability and binding to plasma constituents in rat.
    Greig NH; Soncrant TT; Shetty HU; Momma S; Smith QR; Rapoport SI
    Cancer Chemother Pharmacol; 1990; 26(4):263-8. PubMed ID: 2369790
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antineoplastic drugs in 1990. A review (Part II).
    Black DJ; Livingston RB
    Drugs; 1990 May; 39(5):652-73. PubMed ID: 2191847
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacokinetics of vincristine in the cerebrospinal fluid of subhuman primates.
    Jackson DV; Castle MC; Poplack DG; Bender RA
    Cancer Res; 1980 Mar; 40(3):722-4. PubMed ID: 7471091
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pharmacokinetics of vincristine infusion.
    Jackson DV; Sethi VS; Spurr CL; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Castle MC
    Cancer Treat Rep; 1981; 65(11-12):1043-8. PubMed ID: 7296550
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Pharmacokinetics of vincristine sulfate in adult cancer patients.
    Sethi VS; Jackson DV; White DR; Richards F; Stuart JJ; Muss HB; Cooper MR; Spurr CL
    Cancer Res; 1981 Sep; 41(9 Pt 1):3551-5. PubMed ID: 7260915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
    Early AP; Preisler HD; Slocum H; Rustum YM
    Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics of vincristine in the cerebrospinal fluid of humans.
    Jackson DV; Sethi VS; Spurr CL; McWhorter JM
    Cancer Res; 1981 Apr; 41(4):1466-8. PubMed ID: 6260340
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.